Bone Biologics
About:
Bone Biologics is focused on developing and marketing orthobiologic products.
Website: http://bonebiologics.com
Twitter/X: saeintl
Top Investors: Musculoskeletal Transplant Foundation, Hankey Capital, Orthofix
Description:
Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development.
Total Funding Amount:
$38.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Burlington, Massachusetts, United States
Founded Date:
2004-01-01
Contact Email:
contact(AT)bonebiologics.com
Founders:
Michael Schuler
Number of Employees:
1-10
Last Funding Date:
2024-08-02
IPO Status:
Public
Industries:
© 2025 bioDAO.ai